News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Breast cancer cell
Existing cancer drugs have potential to benefit thousands more patients

31/07/23

Existing targeted cancer drugs could help even more patients, including some with the most common type of breast cancer, scientists have discovered.
Kaposi sarcoma by Yale Rosen
Scientists uncover the ‘Rosetta stone’ of sarcoma research to personalise treatment

27/07/23

Scientists have unveiled the first and largest encyclopaedia of protein alterations in soft tissue sarcomas – opening the door to a new era of understanding and treatment for this group of rare cancers.
Sporting Champions Greg Rutherford (left) and Erin Kennedy (right) posing on a clifftop with the sea and beach behind them as they hold the custom trainers so you can see the words FINISH and CANCER on the soles.
Sporting champions spearhead race to finish cancer

26/07/23

Olympic gold medallist Greg Rutherford MBE and Paralympic gold medallist Erin Kennedy MBE launch an inspirational run for the ICR across 100 miles of British coastline – which will see ‘FINISH CANCER’ imprinted 167,000 times in the sand.
royalmarsden_28783270279 Nick Turner 547x410
ESMO 2023: Professor Nicholas Turner wins prestigious ESMO Award for Translational Research

20/07/23

Professor Nicholas Turner, Professor of Molecular Oncology at The Institute of Cancer Research, London, and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, where he is also Head of the Ralph Lauren Centre for Breast Cancer Research, has received the Translational Research Award by the European Society for Medical Oncology (ESMO).
KRAS-mutated colorectal cancer cells
New AI drug discovery collaboration aims to design new precision cancer drugs

13/07/23

Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future.
We Dance For Life with two laurels from film festivals. A person with fluorescent hair and make up.
'We Dance for Life' film celebrating cancer research wins award at international film festival

11/07/23

'We Dance for Life', a creative film that celebrates scientists from The Institute of Cancer Research, London, and The London Cancer Hub, has won the Best Dance Experimental award at the Experimental, Dance & Music Film Festival in the USA and Canada.
ICR Logo
Radiotherapy boost cuts breast cancer treatment time by at least one week

01/07/23

Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to the IMPORT HIGH trial.
Elephant in grassland on cloudy day facing camera
Animal kingdom-wide AI tool could help unravel cancer complexity

29/06/23

An international study led by ICR scientists has accurately categorised tumour and immune cells of non-human animal species by applying an artificial intelligence (AI) algorithm that was trained on human lung cancer samples.
Immunofluorescent image of autophagosomes in multiple myeloma cells 547x410px
Next-generation trial shows five-drug combo can keep ‘ultra-high-risk’ bone marrow cancer at bay

23/06/23

Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown.
melanoma-cells-547x410
Untapping the full potential of immunotherapies for more people with cancer

06/06/23 - Nafisa Sayani-Bromley

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential.
ICR Logo
ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment

04/06/23

A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study.
High-resolution 3D structure of the SIN3B human protein complex.
Detailed structure of understudied cell division ‘nanomachine’ revealed

31/05/23

Researchers have revealed, at high-resolution, the structure of a human protein complex named SIN3B, which is a ‘nanomachine’ involved in regulating cell division – a fundamental process for life which, if it becomes uncontrolled, can lead to cancer.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.